Algernon Pharmaceuticals Inc. (CSE:AGN)
0.0800
0.00 (0.00%)
Oct 10, 2025, 10:31 AM EDT
Algernon Pharmaceuticals Market Cap
Algernon Pharmaceuticals has a market cap or net worth of CAD 2.74 million as of October 10, 2025. Its market cap has decreased by -9.88% in one year.
Market Cap
2.74M
Enterprise Value
2.65M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since February 1, 2016, Algernon Pharmaceuticals's market cap has decreased from 17.71M to 2.74M, a decrease of -84.52%. That is a compound annual growth rate of -17.51%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 9, 2025 | 2.74M | 43.40% |
Dec 31, 2024 | 1.91M | 50.70% |
Dec 29, 2023 | 1.27M | -75.16% |
Dec 30, 2022 | 5.10M | -25.66% |
Dec 31, 2021 | 6.87M | -78.12% |
Dec 31, 2020 | 31.38M | 695.28% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Feb 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Curaleaf Holdings | 3.45B |
Green Thumb Industries | 2.93B |
Trulieve Cannabis | 2.37B |
dentalcorp Holdings | 2.17B |
Sienna Senior Living | 1.74B |
WELL Health Technologies | 1.42B |
Cronos Group | 1.39B |
Extendicare | 1.24B |